New eczema ointment enters first human safety tests
NCT ID NCT06744569
First seen Nov 20, 2025 · Last updated May 02, 2026 · Updated 18 times
Summary
This early-stage study tests a new ointment called CU-10101 in 64 people—first in healthy volunteers, then in those with mild-to-moderate atopic dermatitis (eczema). The main goal is to check safety and how the body handles the ointment, not yet to prove it works. Participants are randomly assigned to get the real ointment or a placebo (vehicle) without knowing which.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.